Genetically engineered mouse models (GEMMs), orthotopic pancreatic implants in immunocompetent models, xenografts
Milestones
Beginning
Molecular mechanism linking tPA and pancreatic cancer progression
Role of tPA in Alzheimer Disease
The group is settled at PRBB

Gal-1 as a new receptor for tPA in pancreatic cancer
CPEB4 as a key protein dictating tumor cell reprogramming
Gal-1 as a pancreatic cancer target
